We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OKYO market cap is 31.66M. The company's latest EPS is GBP -0.4314 and P/E is -2.87.
| Quarter End | |||||
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.47M | -1.22M | -2.16M | -3.73M | -9.83M |
| Net Income | -3.76M | -1.21M | -2.26M | -3.98M | -11.01M |
| Quarter End | |||||
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 583k | 483k | 5.14M | 3.27M | 4.22M |
| Total Liabilities | 328k | 596k | 1.28M | 1.03M | 5.88M |
| Total Equity | 255k | -113k | 3.85M | 2.24M | -1.66M |
| Market Cap | 31.66M |
| Price to Earnings Ratio | -2.87 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.66 |
| Price to Book Ratio | -19.03 |
| Dividend Yield | - |
| Shares Outstanding | 25.52M |
| Average Volume (1 week) | 25.41k |
| Average Volume (1 Month) | 34.3k |
| 52 Week Change | -37.34% |
| 52 Week High | 3.07 |
| 52 Week Low | 1.09 |
| Spread (Intraday) | 0.06 (4.69%) |
| Company Name | OKYO Pharma Ltd |
| Address |
martello court guernsey GY1 3HB |
| Website | https://www.okyopharma.com |
| Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
